EN 中文
Home Strategic Partnerships News Contact us
TOTAL:41 NEWS
NTC010 Approved by The Hainan Provincial Medical Products Administration for the Import as an Urgently Needed Drug
read
2021-08-02
405
Podcast Series Episode 2: Dry Eye Disease prevalence in China and Zhaoke’s potential treatment solution
read
2021-07-30
916
Zhaoke Ophthalmology’s IND Application for Phase III Clinical Trial of NVK-002 for Myopia Treatment in China Accepted for Review by CDE
read
2021-07-16
281
Zhaoke Ophthalmology’s Last Patient Completed Treatment for Phase III Clinical Trial of Cyclosporine A (CsA) Ophthalmic Gel for Dry Eye Disease, New Drug Application Planned Around the End of 2021
read
2021-07-13
251
Podcast Series Episode 1: Myopia prevalence in children and adolescents and Zhaoke’s potential treatment solution
read
2021-07-05
313
>
Guangzhou Headquarters
Tel: 020-39062888
E-mail: info@zkoph.com
Add: No. 1 Meide 3rd Road, Pearl River Industrial Park, Nansha District, Guangzhou
Hong Kong Headquarters
Tel: (852)23145100
E-mail: info@zkoph.com
Add: Unit 716, 7/F, Building 12W Phase 3, Hong Kong Science Park Shatin, Hong Kong
Wechat
Guangzhou Headquarters
Tel: 020-39062888
E-mail: info@zkoph.com
Add: No. 1 Meide 3rd Road, Pearl River Industrial Park, Nansha District, Guangzhou
Hong Kong Headquarters
Tel: (852)23145100
E-mail: info@zkoph.com
Add: Unit 716, 7/F, Building 12W Phase 3, Hong Kong Science Park Shatin, Hong Kong
Wechat